InvestorsHub Logo
Followers 12
Posts 409
Boards Moderated 0
Alias Born 06/19/2018

Re: carlton sheets post# 60467

Sunday, 09/23/2018 6:29:05 PM

Sunday, September 23, 2018 6:29:05 PM

Post# of 111075
Nailed it Carlton!

If they get 20 MD's signed by EOY (close to half-way in July alone), kit revenue could easily be $200,000 PER MONTH if those doctors only use 10 kits per month (assuming $1K in kit margin) which is very conservative IMHO. That doesn't even factor the upfront $20k per doctor licensing fee or separation machine revenues.

If 20 docs use 30 kits a month, that's $600,000 per month potential.

When they get 100 doctors (maybe a year or more or less?) and those 100 MD's globally use 10 kits a month, that's $1,000,000 per MONTH in potential kit revenue. Add in $2M from licensing fees and ?$? from cell separation machine sales and we're talking real movement here.

1B OS (if it ever gets there) won't matter with all that $$ coming in.

If we trade at $0.0244 with near zero revenue, imagine what this will trade at with millions in revenue. Many Biotechs trade in the $$'s and they have zero revenue or proof of concept in sight. We have both!

GO $CELZ!

All posts my own opinions. Not investment advice.


-- Narrow is the way and few are those who find it. --

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CELZ News